Abiopharma

📋 Monroe Terilyn J. (Officer) plans to sell 10K shares of Guardant Health, Inc. (at $112.07 each, total $1.1M) Filed: Jan 07, 2026 | ID: 000025

Dulac Edward J III 🔴 sold 6.4K shares of Intellia Therapeutics, Inc. (NTLA) at $9.21 Transaction Date: Jan 05, 2026 | Filing ID: 006275

New Form S-3ASR - Phathom Pharmaceuticals, Inc. Filed: 2026-01-07 AccNo: 0001193125-26-006262 Size: 1 MB

(99% Neutral) PHATHOM PHARMACEUTICALS, INC. (PHAT) Reports Q1 2026 Financial Results

New Form SCHEDULE 13D/A - DBV Technologies S.A. Filed: 2026-01-07 AccNo: 0001104659-26-001744 Size: 63 KB

Dube Michael P 🔴 sold 3.0K shares of Intellia Therapeutics, Inc. (NTLA) at $9.21 Transaction Date: Jan 05, 2026 | Filing ID: 006264

📋 MOHAMED ISSA (Officer) plans to sell 11K shares of INCYTE CORPORATION (at $109.07 each, total $1.2M) Filed: Jan 07, 2026 | ID: 000223

Bruker - Bruker Corporation to Present at the J.P. Morgan Healthcare Conference

Mirum Pharma - Mirum Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference

Monte Rosa Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Phathom Pharmaceuticals Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results

Kiniksa Pharmaceuticals to Present at 44th Annual J.P. Morgan Healthcare Conference

Genelux Corporation Announces Proposed Public Offering of Common Stock

AMGEN TO PRESENT AT THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

Battaglia Silvana 🟢 acquired 27 shares of Cencora, Inc. (COR) at $287.09 Transaction Date: Dec 31, 2025 | Filing ID: 000002